Could a bone marrow shot stop arthritis after ACL surgery?

NCT ID NCT06311513

Recruiting now Disease control Sponsor: Hospital for Special Surgery, New York Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a concentrated bone marrow injection (cBMA) given during repeat ACL surgery can reduce knee pain and signs of arthritis. About 40 adults aged 18-55 who need a second ACL repair will receive either cBMA plus surgery or surgery alone. Researchers will track pain, inflammation, and knee function for two years to see if the treatment helps control post-traumatic osteoarthritis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACL INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anterior Cruciate Ligament Injuries osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACL INJURY ANTERIOR CRUCIATE LIGAMENT INJURIES BONE MARROW ASPIRATE CONCENTRATE POST-TRAUMATIC OSTEOARTHRITIS OF KNEE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Emory Orthopaedics & Spine Center
RECRUITING

Atlanta, Georgia, 30097, United States
Hospital for Special Surgery
RECRUITING

New York, New York, 10021, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact